Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Ugo

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Recenti Progressi in Medicina|March 22, 2022
[The organization and staff of a centralized Clinical Trial Center: the Alessandria model.]Annalisa Roveta, Francesca Ugo, Marta Betti, et al.
Recenti Progressi in Medicina|October 2, 2025
Annalisa Roveta, Luigi Mario Castello, Francesca Ugo, et al.
Recenti Progressi in Medicina|April 13, 2026
Awareness of environmental diseases: a survey in a high-exposure areaCarlotta Bertolina, Carolina Pelazza, Roberta Di Matteo, et al.
Journal of Preventive Medicine and Hygiene|June 8, 2026
Developing health research impact assessment in Italy: the case of the Piedmont RegionGuido Resani, Guglielmo Pacileo, Erica Picasso, et al.
Applied Clinical Informatics|June 18, 2025
Developing Mobile Apps to Support Clinical Management of HIV Patients: An Observational StudyAnnalisa Roveta, Massimo Canonico, Alessia Francese, et al.
Viruses|October 26, 2024
Evaluation of a Commercial Rapid Molecular Point-of-Care Assay for Differential Diagnosis Between SARS-CoV-2 and Flu A/B Infections in a Pediatric SettingPaolo Bottino, Costanza Massarino, Christian Leli, et al.
Minerva Medica|April 5, 2024
How primary care research can be improved in clinical practice? An Italian case studyAnnalisa Roveta, Guglielmo Pacileo, Mauro Cappelletti, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST ScoreFederica Grosso, Matilde Mannucci, Francesca Ugo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2024
Erratum to "Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813-819]"Maria Carmela Piccirillo, Quincy Chu, Penelope Bradbury, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 25, 2023
Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171)Maria Carmela Piccirillo, Quincy Chu, Penelope Bradbury, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Recenti Progressi in Medicina|March 22, 2022
[The organization and staff of a centralized Clinical Trial Center: the Alessandria model.]Annalisa Roveta, Francesca Ugo, Marta Betti, et al.
Recenti Progressi in Medicina|October 2, 2025
Annalisa Roveta, Luigi Mario Castello, Francesca Ugo, et al.
Recenti Progressi in Medicina|April 13, 2026
Awareness of environmental diseases: a survey in a high-exposure areaCarlotta Bertolina, Carolina Pelazza, Roberta Di Matteo, et al.
Journal of Preventive Medicine and Hygiene|June 8, 2026
Developing health research impact assessment in Italy: the case of the Piedmont RegionGuido Resani, Guglielmo Pacileo, Erica Picasso, et al.
Applied Clinical Informatics|June 18, 2025
Developing Mobile Apps to Support Clinical Management of HIV Patients: An Observational StudyAnnalisa Roveta, Massimo Canonico, Alessia Francese, et al.
Viruses|October 26, 2024
Evaluation of a Commercial Rapid Molecular Point-of-Care Assay for Differential Diagnosis Between SARS-CoV-2 and Flu A/B Infections in a Pediatric SettingPaolo Bottino, Costanza Massarino, Christian Leli, et al.
Minerva Medica|April 5, 2024
How primary care research can be improved in clinical practice? An Italian case studyAnnalisa Roveta, Guglielmo Pacileo, Mauro Cappelletti, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST ScoreFederica Grosso, Matilde Mannucci, Francesca Ugo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2024
Erratum to "Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813-819]"Maria Carmela Piccirillo, Quincy Chu, Penelope Bradbury, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 25, 2023
Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171)Maria Carmela Piccirillo, Quincy Chu, Penelope Bradbury, et al.
Pageof 1